VISTASEAL

INSTITUTO GRIFOLS SA🇨🇦 Health Canada

Approval Id: 905c9f57445fbb5f
Drug Approval Canada Name: VISTASEAL
Product Name: VISTASEAL
Status: Marketed
Status Date: 2022-01-19
Original Market Date: 2022-01-19
Din: 02514230
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Topical
Schedule: Schedule D
Ahfs: 20:28.16
Atc Original: B02BD30 THROMBIN
Atc Name: b 02 bd 30
Aig Number: 0252708002
Company Name: INSTITUTO GRIFOLS SA
Company Address: Poligono Levante. C/ Can Guasch, 2, Parets Del Valles, Barcelona, Spain, 08150
Company Detail Path: /organization/instituto-grifols-sa

FIBRINOGEN (HUMAN)

160 MG / 2 ML

THROMBIN (HUMAN)

1000 UNIT / 2 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

905c9f57445fbb5f

Type

Standard